http://venturebeat.com/2007/06/05/amgen-buys-kidney-disease-biotech-ilypsa-for-420m/ News About Tech, Money and Innovation Tue, 24 Nov 2009 05:19:25 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/06/05/amgen-buys-kidney-disease-biotech-ilypsa-for-420m/comment-page-1/#comment-614616 WILLIAM MCARTHUR Sun, 04 Nov 2007 06:43:48 +0000 http://venturebeat.com/2007/06/05/amgen-buys-kidney-disease-biotech-ilypsa-for-420m/#comment-614616 do you have a drug that can help me ? I have kidney desease.. thank you do you have a drug that can help me ? I have kidney desease..
thank you

]]> http://venturebeat.com/2007/06/05/amgen-buys-kidney-disease-biotech-ilypsa-for-420m/comment-page-1/#comment-601778 VentureBeat » Amgen, Relypsa and the art of the biotech-spinout-startup-restart Mon, 29 Oct 2007 22:20:20 +0000 http://venturebeat.com/2007/06/05/amgen-buys-kidney-disease-biotech-ilypsa-for-420m/#comment-601778 [...] That’s more or less what Amgen has just done in launching Relypsa, a new Santa Clara, Calif., biotech just spun out of the big biotech’s Ilypsa unit. Relypsa is basically a full restart of Ilypsa — thus the name, I suppose — which Amgen acquired earlier this year for roughly $420 million (see our coverage here). [...] [...] That’s more or less what Amgen has just done in launching Relypsa, a new Santa Clara, Calif., biotech just spun out of the big biotech’s Ilypsa unit. Relypsa is basically a full restart of Ilypsa — thus the name, I suppose — which Amgen acquired earlier this year for roughly $420 million (see our coverage here). [...]

]]>